Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver. Issue 1 (July 2015)

• Record Type: Journal Article
• Authors: Tagawa, Hirotsune; Irie, Junichiro; Itoh, Arata; Kusumoto, Yukie; Kato, Mari; Kobayashi, Nana; Tanaka, Kumiko; Morinaga, Rieko; Fujita, Masataka; Nakajima, Yuya; Morimoto, Kohkichi; Sugizaki, Taichi; Kawano, Yoshinaga; Yamada, Satoru; Kawai, Toshihide; Watanabe, Mitsuhiro; Itoh, Hiroshi
• Is Part Of: Diabetes research and clinical practice. Volume 109:Issue 1(2015)
• Page Start: 85
• Page End: 94
• Publication Date: 2015-07
• Subjects: Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2015.04.025
• Languages: English
• ISSNs: 0168-8227

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Bile acid binding resin improved hepatic insulin sensitivity by reducing cholesterol but not triglyceride in the liver.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Fatty liver shionogi mice developed hepatic fat accumulation without dietary intervention.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Bile acid binding resin improved glycemic controls in the patients with type 2 diabetes without reducing fat mass.</p> </list-item> </list> </p> </sec> </abstract>